Respiratory Syncytial Virus Maternal Vaccination in Infants below 6 Months of Age: Meta-Analysis of Safety, Immunogenicity, and Efficacy

CONCLUSIONS: Not only does antenatal RSV vaccination look safe and immunogenic in vaccinated mothers, but it also reliably provides effective antibody levels in infants and diminishes RSV-related severe disease in infants under 6 months of age.PMID:38286126 | DOI:10.1159/000536031

Source: Neonatology - January 29, 2024 Category: Perinatology & Neonatology Authors: Muhammad Pradhika Mapindra Muhammad Pradhiki Mahindra Paul McNamara Malcolm G Semple Howard Clark Jens Madsen Source Type: research